Azathioprine Dosing in Lupus

Maintenance Therapy Dosing (Primary Indication)

The American College of Rheumatology recommends azathioprine as maintenance therapy after initial induction treatment for lupus nephritis, with a standard maintenance dose of 2 mg/kg/day combined with low-dose prednisone (2.5-5 mg/day), and continued for at least 3-5 years 1, 2
Maintenance therapy with azathioprine follows initial induction with mycophenolic acid, cyclophosphamide, or multitarget therapy 1, 2

For systemic lupus without renal involvement, azathioprine dosing follows similar principles, with a dose range of 1-3 mg/kg/day (typically 50-200 mg daily in adults) 3

The European League Against Rheumatism recommends TPMT testing is mandatory before initiating azathioprine to prevent life-threatening pancytopenia, and it is contraindicated in patients with very low/absent TPMT activity 4, 3
Patients with low TPMT activity require dose reduction or alternative therapy, while patients with high TPMT activity may require doses at the higher end of the range 4, 3

The British Society of Gastroenterology recommends starting azathioprine conservatively and adjusting based on response and metabolite levels, with an initial adult dose of 50-100 mg daily, then titrate upward 4
The target therapeutic range for 6-TGN is 100-300 pmol/8×10⁸ RBCs (pediatric data) 4

The American Association for the Study of Liver Diseases recommends hematologic surveillance is essential to detect cytopenia, with weekly complete blood counts for first 8 weeks, then at least every 6 months 4, 3
Reduce dose if mild cytopenia develops; discontinue if severe, and monitor liver function tests regularly 4

The British Journal of Dermatology recommends avoiding concurrent allopurinol due to risk of severe myelosuppression requiring dose reduction to 25% of standard dose 3

The American College of Obstetricians and Gynecologists considers azathioprine one of the few "safe" immunosuppressants in pregnancy with no increased fetal malformation rate 5
Azathioprine is contraindicated during breastfeeding as it appears in breast milk 3

The American Gastroenterological Association recommends a conservative titration approach, starting with 50-100 mg daily and increasing dose gradually after 6-8 weeks if no serious toxicity and inadequate response, with a maximum dose of 2.5 mg/kg/day 6
Azathioprine hepatotoxicity is dose-dependent and associated with high 6-methylmercaptopurine metabolite levels, and hepatotoxicity is more common at doses ≥200 mg daily 6
Consider repeat liver biopsy if hepatotoxicity is suspected in patients with autoimmune hepatitis overlap 6
Therapeutic response typically occurs after 6-8 weeks; minimum adequate trial is 12 weeks 6
Long-term continuation is appropriate for responders, but attempt gradual dose reduction (0.5 mg/kg or 25 mg decrements every 4 weeks) to find the lowest effective maintenance dose 6